Qube Research & Technologies LTD Zomedica Corp. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.16 - $0.23 $4,819 - $6,927	-30,121 Reduced 45.06%	36,724 $6,000
Q2 2023 Aug 14, 2023	SELL	$0.19 - $0.22 $45,603 - $52,804	-240,020 Reduced 78.22%	66,845 $13,000
Q1 2023 May 15, 2023	BUY	$0.16 - $0.29 $19,134 - $34,681	119,591 Added 63.86%	306,865 $64,000
Q4 2022 Feb 14, 2023	BUY	$0.16 - $0.25 $28,083 - $43,880	175,521 Added 1493.41%	187,274 $29,000
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.38 $97,007 - $184,313	-485,035 Reduced 97.63%	11,753 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.2 - $0.34 $99,357 - $168,907	496,788 New	496,788 $109,000
Q2 2021 Aug 13, 2021	SELL	$0.72 - $1.46 $41,389 - $83,929	-57,486 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$0.35 - $2.7 $20,120 - $155,212	57,486 New	57,486 $91,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.